![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1629612
±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ½ÃÀå : ¿ëµµº°, ÆÄÀ庰, µð¹ÙÀ̽º À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°Photobiomodulation Market, By Application, By Wavelength, By Type of Device (Low-Level Laser Therapy Devices, Light Emitting Diode Devices, and Other Devices), By End User, By Geography |
¼¼°è ±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ½ÃÀåÀº 2024³â 2¾ï 3,030¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö 10.2%ÀÇ CAGR·Î 2031³â¿¡´Â 4¾ï 5,510¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í¼ ¹üÀ§ | º¸°í¼ »ó¼¼ | ||
---|---|---|---|
±âÁØ ¿¬µµ | 2023³â | 2024³â ½ÃÀå ±Ô¸ð | 2¾ï 3,030¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2019-2023³â | ¿¹Ãø ±â°£ | 2024-2031³â |
¿¹Ãø ±â°£ 2024-2031³â CAGR: | 10.20% | 2031³â °¡Ä¡ ¿¹Ãø | 4¾ï 5,510¸¸ ´Þ·¯ |
±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ¶Ç´Â Àú¼öÁØ ±¤Ä¡·á´Â ºûÀ» ÀÌ¿ëÇÏ¿© ¼¼Æ÷ ±â´ÉÀ» ÀÚ±ØÇϰųª ¾ïÁ¦ÇÏ´Â Ä¡·á¹ýÀÔ´Ï´Ù. ±¤¼± ¿ä¹ýÀÇ ÀÏÁ¾À¸·Î, ºÎ»óÀ̳ª Áúº´À» ¾Î°í ÀÖ´Â ½Åü ºÎÀ§¿¡ °¡½Ã±¤¼± ¶Ç´Â ±ÙÀû¿Ü¼±À» Á¶»çÇÏ´Â Ä¡·á¹ýÀÔ´Ï´Ù. ºûÀº ½ÃÅäÅ©·Ò c »êÈÈ¿¼Ò¿Í °°Àº ƯÁ¤ ±¤¼ö¿ëü¿¡ Èí¼öµÇ¾î ¼¼Æ÷ ±â´É Á¶Àý, ¿°Áõ °¨¼Ò, ¼¼Æ÷ ¿¡³ÊÁö Áõ°¡¸¦ ¸ñÇ¥·Î ¼¼Æ÷ ´ë»ç¿¡ º¯È¸¦ °¡Á®¿É´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ºñħ½ÀÀû Ä¡·á Á¢±Ù¹ý¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Áö³ ¸î ³â µ¿¾È ¼¼°è ±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ½ÃÀåÀº °·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.
±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ¼¼°è ½ÃÀåÀº ³ëÀÎ Àα¸ Áõ°¡, ½Å°æ Áúȯ ¹× ¸¸¼º »óóÀÇ À¯º´·ü Áõ°¡, ºñħ½ÀÀû Ä¡·á¹ý¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Á¦ÇÑµÈ ÀÓ»óÀû Áõ°Å, ºÒÃæºÐÇÑ »óȯ Á¤Ã¥, ³ôÀº Àåºñ °ü·Ã ºñ¿ë µîÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ì¿ë ½Ã¼ú¿¡¼ ±¤»ýüÁ¶ÀýÀÇ ÀÀ¿ë ºÐ¾ß °³Ã´°ú °¡Á¤¿ë ±â±âÀÇ µîÀåÀº ½ÃÀå È®´ë¿¡ Å« ±âȸ°¡ µÉ °ÍÀÔ´Ï´Ù. Áö¿ªÀûÀ¸·Î´Â ºÏ¹Ì°¡ ±â¼ú ¹ßÀü°ú ¿¬±¸ ÀÚ±Ý È®º¸·Î ÀÎÇØ ÇöÀç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á °ü±¤°ú ÇコÄɾî ÅõÀÚ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ º¸°í¼´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®ÇÏ¿© ¼¼°è ±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ½ÃÀå¿¡ ´ëÇØ Á¶»çÇß½À´Ï´Ù.
´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.
±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
ÁÖ¿ä ±â¾÷Àº Alcon Inc., THOR Photomedicine Ltd., BioLight Technologies LLC, Erchonia Corporation, Vielight Inc, Noveon Inc., Apira Science Inc., LightForce Therapy, Zynex Medical, BTL Industries, LaserStar Technologies, Meditech, QRS Global µîÀÔ´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ¼¼°è ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ±¤¹ÙÀÌ¿À¸ðµâ·¹ÀÌ¼Ç ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.
The global photobiomodulation market is estimated to be valued a USD 230.3 Mn in 2024 and is expected to reach USD 455.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 230.3 Mn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 10.20% | 2031 Value Projection: | US$ 455.1 Mn |
Photobiomodulation or low-level light therapy is a treatment method that uses light to stimulate or inhibit cellular function. It is a form of phototherapy involving the exposure of an injured or diseased body part to visible or near-infrared light. The light is absorbed by specific photoacceptors like cytochrome c oxidase which leads to changes in cell metabolism aimed at modulating cellular function, reducing inflammation, and increasing cellular energy. With the growing prevalence of chronic diseases and increasing awareness about non-invasive therapeutic approaches, the global market for photobiomodulation is witnessing strong growth over the past few years.
The global photobiomodulation market is driven by rising geriatric population, increasing incidence of neurological disorders and chronic wounds, and growing preference for non-invasive treatment modalities. However, limited clinical evidence, inadequate reimbursement policies, and high costs associated with equipment are restraining the market growth. Developing applications of photobiomodulation in cosmetic procedures and emergence of home-use devices presents significant opportunities for market expansion. Geographically, North America dominates the market currently owing to technological advancements and availability of funding for research. However, Asia Pacific is expected to witness the fastest growth during the forecast period with increasing medical tourism and healthcare investments.
This report provides in-depth analysis of the global photobiomodulation market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global photobiomodulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Alcon Inc., THOR Photomedicine Ltd., BioLight Technologies LLC, Erchonia Corporation, Vielight Inc., Lumenis Ltd., Aspen Laser Systems, Noveon Inc., Apira Science Inc., LightForce Therapy, Zynex Medical, BTL Industries, LaserStar Technologies, Meditech, and QRS Global
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global photobiomodulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global photobiomodulation market